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Mitochondria maintain a circular 16.6 kb DNA genome (mtDNA) encoding 2 ribosomal RNAs, 22 transfer RNAs and 13 open reading frames for electron transport chain 
(ETC) complex subunits. Mitochondria are also the major source of 
ATP and the site of oxidative phosphorylation (OXPHOS) and the 
tricarboxylic acid (TCA) cycle, which are essential for cellular res-
piration. In addition, mitochondria facilitate numerous metabolic 
reactions required for macromolecular synthesis, including the pro-
duction of lipids, deoxynucleotide triphosphates, heme, iron–sulfur 
clusters and amino acids1.
The five complexes of the OXPHOS machinery perform redox 
reactions using NADH and succinate to drive the majority of cellu-
lar ATP production through ATP synthase1. While most OXPHOS 
proteins are encoded in the nucleus, key components of all com-
plexes, except complex II, are encoded by mtDNA. The function 
and maintenance of the OXPHOS machinery depends on the 
integrity and transcription of mtDNA, precursor RNA process-
ing and the assembly of mitochondrial-specific ribosomes and 
translation2. Other factors affecting the OXPHOS system include 
the coordinated movement of nuclear-encoded proteins into the 
mitochondria, and the ordered assembly and membrane inser-
tion of mature OXPHOS complexes that is thought to take place 
in close proximity to the mtDNA and mitochondrial inner mem-
brane2. Deficiencies in the assembly or function of the OXPHOS 
machinery underlies many severe human diseases3. Paradoxically, 
some OXPHOS defects extend lifespan in both worms and flies, 
in some cases in a manner that is dependent on increased reactive 
oxygen species (ROS) production4–6, and is classically associated 
with premature ageing1.
Exonuclease 3′ –5′ domain-containing 2 (EXD2), which is 
encoded in the nucleus, has previously been implicated in DNA 
repair and DNA damage sensitivity7–10. Here, we report that EXD2 
is a mitochondrial ribonuclease that is required for mitoribo-
some integrity and efficient mitochondrial translation. EXD2 
depletion led to widespread metabolic defects, decreased respira-
tion and increased ROS. At the organismal level, deficiency in the 
Drosophila melanogaster EXD2 orthologue CG6744 resulted in 
developmental delays, premature female germ stem cell attrition 
and a dramatically extended lifespan. Collectively, our results define 
a critical role for EXD2 in mitochondrial homeostasis.
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EXD2 is a mitochondrial protein
EXD2 encodes a 3′ –5′ exonuclease (EXO) domain similar to one 
encoded by WRN, a gene in which mutations cause Werner’s syn-
drome progeria11 (Supplementary Fig.  1a). Additionally, EXD2 
has a highly conserved carboxy-terminal HNH endonuclease-like 
domain characterized by tandem CXXC motifs (Supplementary 
Fig. 1b–d). As previous reports have suggested a role for EXD2 in 
DNA repair7–9, we examined the localization of this exonuclease. 
EXD2 was predominantly located in the cytoplasm, regardless of 
camptothecin-induced DNA damage, and overlapped substan-
tially with mitochondrial TOM20 (Fig. 1a). Comparative sequence 
analysis identified a putative, amino-terminal mitochondrial tar-
geting sequence (MTS) conserved in most EXD2 homologues 
identified so far (Supplementary Fig. 1e). Overexpression of green 
fluorescent protein (GFP)-tagged EXD2 (EXD2–GFP) or of its 
MTS fused to GFP (MTS–GFP; amino acids 1–61) resulted in a 
mitochondrial GFP signal, whereas the ∆ MTS–GFP (in which 
amino acids 1–61 are deleted) protein was diffusely nucleo-
cytoplasmic and destabilized (Fig.  1b,c). Subcellular fraction-
ation for endogenous EXD2 (Fig. 1d) and transmission electron 
microscopy (TEM) of cells stably expressing streptavidin and 
FLAG (SF)-tagged wild-type EXD2 (EXD2–SF-WT) confirmed 
that EXD2 primarily localized to mitochondria (Fig.  1e and 
Supplementary Fig. 1f,g). In contrast to the outer membrane pro-
teins TOM20 or VDAC1, which are susceptible to proteinase-K 
(PK)-mediated digestion, EXD2 was resistant, a response that is 
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Fig. 1 | EXD2 is a mitochondrial protein. a, Immunofluorescence of endogenous EXD2 in U2OS cells revealed extensive colocalization with the 
mitochondrial TOM20 protein. EXD2 localization was unaltered by treatment with 1 μ M camptothecin (CPT) to induce DNA damage (lower panels). 
Scale bars, 20 µ m. b, EXD2 contains an MTS that is necessary and sufficient for mitochondrial localization. Amino acids 1–61 of EXD2 are sufficient to 
localize GFP to mitochondria (bottom panels). Deletion of amino acids 1–61 of EXD2 leads to diffuse nuclear-cytoplasmic localization (middle panels). 
Scale bars, 15 µ m. Images in a and b represent 1 out of 5 experiments. c, Western blot of GFP fusion proteins with expected sizes indicated. Note poor 
expression and destabilization of ∆ MTS–GFP. Arrowheads indicate the protein of the corresponding label colour. d, Subcellular fractionation (cytoplasm 
(Cyt.), mitochondria (Mito.), nucleus (Nuc.) and chromatin (Chr.)) of EXD2 (enclosed by dashed boxes) in the presence or absence of 1 μ M CPT indicated 
exclusively mitochondrial localization. Data represent 1 out of 3 experiments. e, TEM indicated mitochondrial (dashed outlines) localization of EXD2–SF-
WT. Scale bar, 200 nm. See Supplementary Fig. 1f,g for additional examples. f, Western blot of mitochondria isolated from U2OS cells treated with  
50 μ g ml–1 PK in the presence or absence of Triton X-100 shows that EXD2 is resistant, similar to the OXPHOS subunit ATP5A, indicating inner membrane 
and/or matrix localization. Data in e,f represent 1 out of 2 experiments. Uncropped blots are shown in Supplementary Fig. 9.
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similar to that of the inner membrane ATP5A subunit of ATP 
synthase (Fig.  1f). In addition, while treatment with carbonyl 
cyanide-4-(trifluoromethoxy)phenylhydrazone (FCCP) liberated 
TOM20 from the outer membrane, EXD2 remained relatively 
resistant. This result is similar to ETC components that localize to 
the inner membrane or matrix (Supplementary Fig. 1h). Together, 
these results indicate that EXD2 is an intra-mitochondrial protein 
targeted by an N-terminal MTS.
EXD2 influences cellular metabolism
As mitochondria play a key role in metabolism, we examined 
the impact of EXD2 deficiency using complementary metabolo-
mics approaches12,13. EXD2 depletion (Fig. 2a,b) led to alterations 
in many metabolites, including those of the TCA cycle, antioxi-
dants and glycolysis (Fig.  2c). Using the NMR-based positional 
enrichment by proton analysis (PEPA) technique, we followed 
13C isotope incorporation of glucose or glutamine, which are key 
precursors for numerous metabolites of central carbon metabo-
lism13,14. Pathway enrichment analysis revealed significant altera-
tions in several metabolite classes, including the glutathione cycle, 
amino acid and sugar metabolism, the pentose phosphate path-
way and the TCA cycle (Fig. 2d). Moreover, we observed marked 
defects in the incorporation of glucose-derived carbon into 
many metabolites, whereas glutamine was relatively unaffected 
(Fig. 2e,f). These data indicate that EXD2 is required for glucose 
oxidation through the TCA cycle and glutathione synthesis, sug-
gesting that EXD2-deficient cells may have alterations in ROS or 
antioxidant capacity and rely on glutamine for the generation of 
key metabolites.
EXD2 prevents ROS and is required for OXPHOS activity
To understand the abovementioned effects, we generated EXD2-
knockout (KO) cell lines using CRISPR–Cas9 technology and 
complemented them with EXD2–SF-WT, an EXO domain mutant 
(NUC) or HNH-like domain mutants (C1 and C2)15 (Supplementary 
Figs. 1a,c and 2a). EXD2-deficient cells had reduced glutathione lev-
els (Fig. 3a and Supplementary Fig. 2b), consistent with metabolo-
mics data (Fig. 2), and increased levels of ROS (Fig. 3b). Expression 
of EXD2–SF-WT or treatment with the antioxidant N-acetylcysteine 
(NAC), but not with the EXD2–SF-NUC and C2 mutants, rescued 
ROS levels to that of wild-type cells (Fig. 3b). EXD2-deficient cells 
also exhibited reduced levels of mtDNA (Fig. 3c and Supplementary 
Fig.  2c,d), a phenotype associated with increased ROS levels and 
defective respiration16. mtDNA reduction was independent of 
clear changes in mitochondrial mass (Fig. 3d,e and Supplementary 
Fig. 2e) or mtDNA replication (Supplementary Fig. 2f) and could be 
rescued with expression of EXD2–SF-WT and partially with NAC 
treatment (Fig. 3c and Supplementary Fig. 2d).
Growth of EXD2-deficient cell lines was indistinguishable from 
wild-type parental U2OS cells cultured in rich medium containing 
glucose and glutamine (Fig.  3f). However, we observed impaired 
growth of EXD2-KO1 cells cultured in media lacking glutamine 
(Fig. 3g and Supplementary Fig. 2g), which was restored by treat-
ment with EXD2–SF-WT but not EXD2–SF-NUC or C2 mutants 
(Fig. 3g). Moreover, NAC did not rescue the impaired growth, indi-
cating that the growth defects of EXD2-KO1 cells were not second-
ary to increased ROS production or sensitivity to hyperoxic culture 
conditions (Fig. 3h,i).
Mitochondrial ROS originates predominantly from com-
plexes I and III of the ETC17, so we examined ETC function by 
measuring oxygen consumption rates (OCRs) in both U2OS and 
MDA-MB-231 cells. Compared with parental or EXD2–SF-WT 
complemented cells, EXD2-KO1 cells exhibited reduced OCRs 
and ATP-linked respiration that could not be efficiently rescued 
by EXD2 mutants (Fig.  3j and Supplementary Fig.  2h). In addi-
tion, extracellular acidification rates (ECARs) were elevated in 
EXD2-KO or mutant cells, indicative of increased aerobic glycolysis 
and lactate production that can accompany defective OXPHOS18 
(Fig. 3k and Supplementary Fig. 2i). NAC partially rescued over-
all OCRs, but mitochondrial ATP-linked respiration remained 
impaired, suggesting that reduced OXPHOS capacity could be one 
of the primary defects leading to increased ROS levels (Fig. 3l and 
Supplementary Fig. 2j).
Metabolomics data indicated that the reduced OCRs could 
reflect impaired glucose usage in EXD2-deficient cells (Fig.  2e,f). 
We tested this hypothesis using specific media and observed an 
increase in OCRs following glucose addition in cells lacking func-
tional EXD2 (Fig. 3m). To more directly confirm a role for EXD2 
in ATP production, we analysed ATP levels using multiple meth-
ods and observed that EXD2-KO1 cells had reduced levels of 
ATP that were rescued by EXD2–SF-WT expression (Fig. 3n and 
Supplementary Fig. 2k,l). Moreover, these defects were not rescued 
by NAC (Fig.  3n and Supplementary Fig.  2k). We therefore con-
cluded that EXD2 deficiency results in impaired mitochondrial 
ATP production, ROS accumulation, reduced mtDNA levels and 
glutamine-dependent cell growth.
EXD2 associates with complex I and the mitoribosome
To determine how EXD2 influences metabolism, we used BioID 
mass spectrometry (BioID-MS) to identify proximity interactors19. 
EXD2-WT and EXD2-C2 fused to a FLAG-tagged BirA* biotin 
ligase (EXD2–BirA*-WT and EXD2–BirA*-C2, respectively) 
were overexpressed in the presence of biotin in human AD293 
cells. While BirA* expression resulted in staining throughout the 
cell, the streptavidin signal was only detected in the cytoplasm 
of biotin-supplemented cells expressing EXD2–BirA*-WT or 
EXD2–BirA*-C2, and this expression pattern colocalized exten-
sively with TOM20 (Fig. 4a). BioID-MS revealed an EXD2 prox-
imity interactome composed almost entirely of mitochondrial 
proteins (Fig. 4b and Supplementary Table 2) and highly enriched 
for components of complex I and the small 28S subunit of the 
mitoribosome (Fig.  4c). The components included almost all of 
the matrix-exposed complex I subunits20, more than 10 subunits 
of the 28S mitoribosome, proteins involved in RNA processing or 
translation and assembly (for example, GRSF1, TACO1, ACAD9 
and LETM1), as well as enzymes implicated in OXPHOS sub-
strate generation (for example, MDH2 and GLS) (Fig. 4c). Most 
interactions were also observed with EXD2-C2, which fails to 
complement phenotypes of EXD2-KO1 cells. However, the repre-
sentation of 28S components was specifically reduced compared 
with EXD2-WT (Fig. 4c and Supplementary Table 2), suggesting 
that the HNH-like domain influences the frequency or affinity of 
this subset of interactors.
An interaction with the complex I subunit NDUFA9 was 
observed in immunoprecipitation (IP)–western blot analyses, 
EXD2-KO1 cells showed minor reductions in the levels of com-
plex I, supercomplexes of complexes I and III, and, to a lesser 
extent, complex V (ATP synthase) and complex I-dependent OCR 
was also reduced (Supplementary Fig.  3a–d). As EXD2 did not 
appear to be present in fully assembled complex I (Supplementary 
Fig.  3b), we analysed the mitoribosome components and read-
ily observed an interaction with DAP3 (28S subunit) that was 
impaired by the EXD2–SF-C2 mutant (Fig.  4d). In contrast, we 
did not see an interaction with the large mitoribosome (39S) sub-
unit MRPL3 or with VDAC1, an outer mitochondrial membrane 
protein, in IP–western blots (Fig.  4d). The mitoribosome asso-
ciation was further validated by confocal microscopy, whereby 
extensive colocalization of endogenous EXD2 and MRPL12 was 
observed (Fig.  4e). This result further established the predomi-
nant mitochondrial localization of EXD2 and suggested that its 
primary functions could be linked to the OXPHOS machinery 
and to the mitoribosome.
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EXD2 facilitates mitochondrial translation
We next examined mitoribosome integrity using sucrose gradi-
ent fractionation. EXD2 co-fractionated with the 28S subunit and 
with the fully assembled 55S mitoribosome, but not with the free 
39S subunit (Fig. 5a, top panels). As early 28S association of EXD2 
suggested that EXD2 has a potential role in or during assembly, 
we analysed ribosome integrity in EXD2-KO1 cells and in cells 
expressing EXD2–SF-C2. In both cases, we observed a clear shift 
of the 28S DAP3 subunit into higher molecular mass complexes 
overlapping with 39S fractions (Fig. 5a, middle and bottom panels). 
RNA analyses revealed increased 12S rRNA and mtDNA encoded 
mRNAs in the aberrant fractions, suggesting that a premature mito-
chondrial mRNA association with the 28S could yield the larger, 
aberrant complexes (Fig. 5b, compare top panels with middle and 
bottom panels). Consistent with this possibility, the profiles of 
RNase A-treated fractions were similar regardless of EXD2 status 
(Supplementary Fig. 4a). The EXD2-SF-C2 mutant protein did not 
visibly co-fractionate with the free 28S subunits, a result that is con-
sistent with the HNH-like domain promoting the 28S association 
(Fig. 5a, bottom panel).
The appearance of aberrant 28S subunits suggested that mito-
chondrial translation could be impaired; therefore we analysed this 
possibility using metabolic pulse labelling21. A strong reduction in 
global mitochondrial translation rates was observed in U2OS and 
RPE1 cells lacking EXD2 (Fig. 5c–f and Supplementary Fig. 4b–e); 
this effect was complemented by EXD2–SF-WT, but not by EXD2–
SF-NUC or C2 mutants. Furthermore, NAC treatment did not influ-
ence the phenotype (Fig. 5f), suggesting that this effect was likely a 
direct result of EXD2 loss. Together, these data indicate that EXD2 
prevents inappropriate mRNA association with mitoribosomes and 
facilitates efficient mitochondrial translation that requires both its 
EXO and HNH-like domains.
EXD2 preferentially binds single-stranded RNA
As EXD2 loss appeared to influence the association of mRNA 
with mitoribosomes, we considered that EXD2 may function as 
an RNase. We examined the activity and specificity of bacterially 
purified EXD2 and that of the WRN exonuclease domain (WRN-
EXO) for comparison. The MTS of EXD2 (1–61) was removed to 
improve  solubility and we generated  the EXD2-NUC mutant (to 
control for contaminating nucleases) and the EXD2-C2 mutant (as 
it fails to complement EXD2-KO1 cells) (Fig. 6a and Supplementary 
Fig. 5a). As previously reported8, EXD2-WT, but not EXD2-NUC, 
exhibited 3′ –5′ exonuclease activity on single-stranded (ssDNA) 
(Supplementary Fig. 5b). In addition, both EXD2-WT and WRN-
EXO exhibited activity on double-stranded DNA (dsDNA), ssRNA, 
both strands of a DNA–RNA hybrid and several other DNA sub-
strates (Fig.  6b–d and Supplementary Fig.  5d–f). Similar activity 
was observed with EXD2-C2, although it was consistently lower, 
indicating that stability or selectivity of the enzyme–nucleic acid 
complex may be affected (Fig.  6e and Supplementary Fig.  5f–g). 
However, when MgCl2 was used as a cofactor, both EXD2-WT and 
EXD2-C2, but not the closely related WRN-EXO, showed stronger 
substrate discrimination, with exonuclease cleavage observed only 
on ssRNA or RNA–DNA hybrids (Fig.  6f–i and Supplementary 
Fig. 5h–k). Quantification of multiple experiments revealed that the 
specific activity of EXD2 increased by approximately threefold on 
ssRNA compared with ssDNA when using MnCl2. In contrast, in 
the presence of MgCl2, EXD2 activity on ssDNA and dsDNA sub-
strates was lost, reduced on hybrids, but similar on ssRNA (Fig. 6j 
and Supplementary Fig. 5l).
To determine whether EXD2 had any binding preference, we 
performed electrophoretic mobility shift assays (EMSAs) on fluo-
rescently labelled substrates. We observed a clear supershift with 
ssRNA, but not with ssDNA or hybrid molecules, when EXD2 was 
added (Fig.  6k). Similarly, EXD2-NUC and EXD2-C2 mutants 
bound preferentially to ssRNA, although the supershift was reduced 
with EXD2-C2 (Fig. 6l,m), and WRN-EXO did not exhibit any obvi-
ous substrate preference (Supplementary Fig. 5m). Together, these 
data demonstrate that EXD2 and WRN have promiscuous MnCl2-
dependent activity on various RNA and DNA substrates in vitro. 
However, EXD2 preferentially binds to ssRNA and can maintain 
its activity on ssRNA in the presence of MgCl2, indicating that it is 
more likely to be the physiological substrate of its activity.
CG6744 influences Drosophila metabolism and development
Given the influence of EXD2 on mitochondrial function, we exam-
ined the impact of depleting the D. melanogaster EXD2 ortho-
logue CG6744 (henceforth referred to as dEXD2) (Supplementary 
Fig.  6a). Consistent with available data22, two peaks of dExd2 
expression were observed in control yellow white flies in early 
embryos (0–4 h) and in pupae (WPP) (Supplementary Fig. 6b,c), 
which are developmental phases associated with high metabolic 
activity23. We obtained flies with a transposon insertion and con-
firmed dExd2 mRNA depletion in homozygous animals (Fig. 7a). 
Similar to human cells, mtDNA levels were lower in mutant ani-
mals and largely rescued by NAC treatment (Fig. 7b), and mito-
chondrial translation rates were reduced in dEXD2-deficient flies 
(Fig. 7c,d). Moreover, overexpressed dEXD2 localized extensively 
to the mitochondria of Drosophila Schneider 2 (S2) cells (Fig. 7e), 
and dEXD2-deficient flies exhibited impaired respiration (Fig. 7f) 
and lower levels of ATP and glutathione (Fig. 7g). Embryos and 
pupae lacking dEXD2 were smaller than controls but appeared 
morphologically normal, suggesting a developmental delay 
(Fig. 7h). In addition, pupariation times were extended, but could 
be normalized by NAC treatment or further extended with para-
quat treatment, which elevates ROS levels (Fig. 7i). These effects 
were not due exclusively to maternal inheritance of defective 
mitochondria, as the expected ratio of normal to runt animals was 
observed following breedings from heterozygous females, which 
transmit intact mitochondria to all offspring, with homozygous 
males (Supplementary Fig. 6d).
EXD2 prevents germ stem cell attrition and regulates lifespan
As mitochondrial dysfunction and ROS extend or diminish lifes-
pan in different experimental settings4–6, we examined the lifespan 
of dEXD2-deficient animals. We observed a slight but significant 
lifespan extension in males that was more dramatic in females and 
normalized by NAC treatment (Fig. 8a and Supplementary Table 1). 
In adult flies, expression of dExd2 was higher in the ovary than 
in the brain or gut (Fig.  8b), and mutants exhibited an acceler-
ated reduction in fecundity that was largely rescued by NAC 
treatment (Fig. 8c). To ascertain the origin of this phenotype, we 
examined the pool of germ stem cells (GSCs) present in control 
and dEXD2-deficient ovaries. As previously described, a progres-
sive GSC decline in control flies was observed24, a phenotype that 
was accelerated in dEXD2-deficient animals and rescued by NAC 
treatment (Fig.  8d,e). Cytological analyses of dEXD2-deficient 
ovaries revealed a disorganized mitochondrial network with 
highly reduced levels of cytochrome c, an essential component 
of the ETC, suggesting a metabolic collapse in the germarium 
where the GSCs and somatic follicle stem cells reside (Fig.  8f). 
These results suggest that EXD2 is crucial for mitochondrial 
homeostasis in vivo and that it prevents excess ROS produc-
tion that retards normal development and causes the premature 
attrition of GSCs, reduced fecundity and extended lifespan25 
(Supplementary Fig. 6e).
Discussion
Our data connects the EXO and HNH-like domains of EXD2 to 
mitochondrial ribosome integrity, translation, OXPHOS activ-
ity and Drosophila germline stem cell maintenance and lifespan. 
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(right) with individual values of three independent experiments shown with the means (s.d.). Quantification of EXD2–SF-C2 with individual values 
of n =  2 independent experiments shown with the means. Schematic representation of detected components is shown below each plot. b, qRT-PCR 
analysis of the sedimentation profile of the indicated mitochondrial transcripts in wild-type, EXD2-KO1 and EXD2–SF-C2 cells. The abundance 
of transcripts in each fraction is shown as a percentage of the total levels. The distribution of fractions containing the 28S, 39S and 55S detected 
by western blotting is shown for reference. Quantification of n =  3 independent experiments is shown for wild-type and EXD2-KO1 cells with all 
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products separated by SDS–PAGE and blotted to PVDF membranes shown for the indicated cell lines. Subsequent western blotting for GAPDH was 
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Supplementary Fig. 9.
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(yellow white, yw) measured by qRT-PCR. Averages from n =  3 independent experiments plotted with the mean (s.d.) (***P =  0.0002 and 0.0003,  
unpaired t-test, two-tailed). b, mtDNA levels analysed using qRT-PCR in flies reared in food with or without NAC. Averages from n =  3 experiments 
plotted with the means (s.d.). **P =  0.0083 female, **P =  0.0013 male, unpaired t-test, two-tailed. c, Phosphorimager scan of mitochondrial translation 
products. Western blot for VDAC (porin) shows equal loading. d, Quantification of n =  3 independent experiments compared with wild-type samples 
with the means (s.d.) shown with individual values. **P =  0.0024, unpaired t-test, two-tailed. e, Confocal immunofluorescence of exogenously 
expressed dEXD2–BirA*-FLAG or BirA*-FLAG protein in Drosophila S2 cells. Extensive colocalization of EXD2–BirA*-FLAG but not BirA*–FLAG is 
observed with the mitochondrial protein ATP5A. Scale bar, 0.2 µ m. Data represent 30 cells from 2 experiments. f, Reduced oxygen consumption in 
dEXD2-deficient flies is not rescued with NAC treatment. Measurements from n =  4 or n =  3 (NAC samples) independent experiments are plotted with 
the means (s.d.). *P <  0.05, ***P <  0.001, one-way ANOVA with Dunnet’s test. g, LC–MS analysis of the indicated metabolites in 1-week-old flies reared 
on normal food or food containing NAC. n =  4 independent biological replicates plotted with the means (s.d.). h, dExd2EY03872 embryos and pupae are 
smaller than controls. Individual values and the means (s.d.) from n =  100 embryos and n =  31 pupae are shown (***P <  0.0001, t-test, two-tailed).  
A representative example pupa of each genotype is shown; scale bar, 500 µ m. i, Delayed pupariation in dExd2EY03872 flies is rescued by NAC and 
enhanced by paraquat (PQT) at doses that do not strongly affect controls. Mean (s.d.) compiled from n =  3 independent experiments with 40 flies 
per point is plotted. Source data and additional statistical information are provided in Supplementary Table 1, and uncropped blots are provided in 
Supplementary Fig. 9.
NATuRE CELL BIOLOGY | VOL 20 | FEBRUARY 2018 | 162–174 | www.nature.com/naturecellbiology 171
© 2018 Nature America Inc., part of Springer Nature. All rights reserved.
Articles NATuRE CELL BIOLOGy
We propose that EXD2 functions as a ribonuclease that prevents 
precocious association of mitochondrial mRNAs with the free 
28S mitoribosomal subunits before 55S assembly. This proposal 
is consistent with the enrichment of 28S proteins observed in the 
BioID-MS data, the fractionation pattern of EXD2, its preference 
for ssRNA and the increased mRNA levels co-fractionating with 
aberrant 28S subunits in EXD2-deficient cells. Similar alterations 
in 28S subunit mobility were observed in cells lacking LRPPRC 
and SLIRP, which influence stability and translation of mitochon-
drial mRNA pools26,27. While we cannot strictly rule out a role for 
EXD2 in mtRNA processing or stability, MitoString28 analysis indi-
cated that the profiles of EXD2-deficient cells were highly similar to 
parental or complemented cells, and most known precursor RNA 
processing events occurred normally (Supplementary Fig.  7a,b), 
indicating that EXD2 is not likely required for global RNA precur-
sor processing or mitochondrial mRNA levels.
The EXO and HNH-like domains are both crucial for EXD2 
function. Extending earlier reports8, we identified additional EXD2 
orthologues, defined by EXO and HNH domains (Supplementary 
Fig.  1a–c). Arabidopsis RRP6L3 is a likely EXD2 orthologue with 
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a high degree of similarity in the HNH domain, although its EXO 
domain is more similar to RRP6 (exosomal RNAse) than WRN and 
it contains an additional HRDC domain absent in metazoan EXD2 
nucleases. EXD2 also appears sporadically in some trypanosome 
lineages; in Leishmania, EXD2 has an additional Z3H1-type zinc 
finger not present in other species. Thus, EXD2 is widely conserved 
and at least three major domain configurations exist, potentially 
reflecting a specialization of function in those organisms.
Our data suggest that the HNH-like motif influences stable 
binding of EXD2 to ssRNA and the 28S subunit (Figs. 4,5), reflected 
by the absence of EXD2–SF-C2 in 28S fractions (Fig.  5a) and its 
reduced RNA binding. The EXD2 HNH-like domain lacks con-
served DH catalytic residues required for activity in other HNH 
endonucleases (Supplementary Fig. 1d). Notably, in fold and func-
tion assignment searches (FFAS), several of the highest scoring 
HNH domains belong to proteins involved in chaperoning assembly 
and insertion of membrane complexes (DotN) or electron transport 
(NapB), suggesting a diverse repertoire of potential functions for 
this domain (Supplementary Fig. 1d).
Both human and Drosophila EXD2 were identified in a genome-
wide short interfering RNA screen for host factors that support 
dengue RNA virus replication; however, a specific role in the viral 
lifecycle has not been reported29. EXD2 was also implicated in DNA 
repair, reported to localize to nuclear chromatin and interact with 
the DNA resection machinery, and identified on collapsed replica-
tion forks in an isolation of proteins on nascent DNA(iPOND)-MS 
screen7–10,30. However, 11 mitochondrial proteins, including 5 mito-
ribosome proteins, were also identified in the iPOND-MS screen30 
with comparable scores. Using reported fractionation methods8, 
we readily identify EXD2 in chromatin fractions (Supplementary 
Fig. 7c), but they were highly contaminated with mitochondria, and 
these points should be considered in light of the data reported here. 
We did not detect EXD2 in the nucleus (Fig. 1 and Supplementary 
Fig. 1h), and overexpressed human and fly EXD2 localized primar-
ily to mitochondria with no clear nuclear staining in immunofluo-
rescence assays (Figs. 1, 4 and 7). This result is consistent also with 
the cytoplasmic localization reported for Arabidopsis RRP6L331. 
Moreover, in an unbiased proteomics approach, we identified almost 
exclusively mitochondrial proteins, none of which has been impli-
cated in DNA repair or replication, except for POLD4 (POLDIP2) 
and ATR, which also have mitochondrial roles32,33 (Fig.  4c and 
Supplementary Table 2).
Consistent with previous reports8, we observed robust 3′ –5′ exo-
nuclease activity, but both EXD2 and WRN showed activity on all 
DNA and RNA substrates tested (Fig. 6 and Supplementary Fig. 5) 
when MnCl2 was used in reactions. In contrast, EXD2 showed clear 
binding and activity on ssRNA in the presence of MgCl2, suggest-
ing that its physiological substrate is RNA. Additionally, we did not 
observe defective RPA focus formation (Supplementary Fig. 7d,e) or 
DNA damage sensitivity in EXD2-deficient cells using several cell 
line backgrounds controlled with complementation (Supplementary 
Fig. 7f–h). We believe that our data strongly indicates that the pri-
mary role of EXD2 is to govern mitochondrial ribosome mRNA 
loading, translation and ATP production through its RNAse and 
potentially other activities. However, we cannot rule out a DNA 
replication or repair role that we have not detected owing to dif-
ferences in technical conditions or cell line backgrounds. Notably, 
phenotypes associated with some translational regulators include 
defects in mitochondrial and nuclear genome maintenance34, and 
there are examples of DNA repair enzyme families with key roles in 
translational regulation35. Moreover, numerous DNA repair nucle-
ases (for example, FEN1 and DNA2) localize to both the nucleus 
and mitochondria36,37.
ROS levels, reproductive capacity, abundance and activity 
of OXPHOS components and global translation have all been 
shown to be major factors influencing lifespan in numerous 
organisms4,6,38–40. Depletion of mitochondrial translational regula-
tors in Saccharomyces cerevisae extends lifespan in a Sir2-dependent 
manner41, but we did not observe alterations in Sir2 mRNA in 
dEXD2-deficient flies, and lifespan extension in females was 
independent of calorie restriction, which is also Sir2 dependent42 
(Supplementary Fig.  7i,j). We propose that the dramatic lifespan 
extension in dEXD2-deficient females is primarily the result of 
ROS-mediated, premature attrition of the GSC pool and loss of 
fecundity (Supplementary Fig. 6e). This proposal is consistent with 
dExd2 expression patterns, the rescue of GSC attrition, fecundity 
and lifespan with NAC treatment, the reduced respiration observed 
in dEXD2-deficient flies, and the close correlation between the age 
of GSC loss and lifespan extension (Fig. 8). An inverse relationship 
between lifespan and reproductive capacity was reported in sev-
eral organisms, including Caenorhabditis elegans and Drosophila25. 
Although multiple mechanisms have been proposed, including 
elevated ROS and antagonistic GSC to soma crosstalk, the precise 
nature of the signal that influences lifespan remains to be clarified43.
While it remains unclear whether EXD2 influences mammalian 
fertility or lifespan, analysis of mRNAs enriched in Xenopus germ 
plasm, which is rich in mitochondria and RNA-binding proteins, 
identified xEXD244; this finding indicates that xEXD2 could play 
a similar role in the vertebrate GSC niche. Patients with intersti-
tial deletions in chromosome 14q24, which includes EXD2 and 18 
neighboring genes, have been reported to have congenital heart 
defects, brachydactyly and intellectual disability45, indicating that 
EXD2 loss may influence human development. However, the 
individual contribution of EXD2 deficiency to these pathologies 
remains unclear. The precise control of mtDNA levels, RNA pro-
cessing, ribosome assembly, translation, and the dynamic composi-
tion and molecular regulation of OXPHOS complexes in mammals 
is critical for normal metabolism and healthy ageing1. Our results, 
and those of others, suggest that many additional regulators of these 
processes have yet to be identified, and their characterization will 
further enhance our understanding of mitochondrial regulation 
and its role in ageing.
Methods
Methods, including statements of data availability and any asso-
ciated accession codes and references, are available at https://doi.
org/10.1038/s41556-017-0016-9.
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Methods
Generation of expression constructs. Human EXD2 was amplified from 
U2OS cell complementary DNA, sequenced and cloned into pENTR/D-TOPO 
(Invitrogen) following the manufacturer’s protocol. EXD2 was subcloned using 
LR clonase into the retroviral vector pLPC-C-SF-TAP generated by subcloning 
the C-SF-TAP cassette (a gift from C. J. Gloeckner, University of Tübingen46) 
into the pLPC-N-Myc plasmid (a gift from T. de Lange; Addgene, plasmid 
number 12540). EXD2 mutants were generated using a QuikChange Lightning 
Site-Directed Mutagenesis kit (Agilent Technologies, 210518-5) according to the 
manufacturer’s instructions. Clones were purified using a PureLink Quick Plasmid 
Miniprep kit (Invitrogen) and the sequence of constructs confirmed. Large-scale 
plasmid purification was performed using a PureYield Plasmid Maxiprep System 
(Promega). Primers sequences are provided in Supplementary Table 3.
Human cell culture. Human cell lines (U2OS, HEK293T, AD293, MDA- 
MB-231 and RPE1) were cultured in Dulbecco’s modified Eagle Medium 
(DMEM; Invitrogen, 41966) supplemented with 10% (v/v) fetal bovine serum 
(FBS; Sigma, F7524-500ML) and 100 U ml–1 penicillin–streptomycin (Reactiva, 
01030311B000) in 5% CO2. In some experiments, cells were treated with 100 μ g ml–1 
chloramphenicol (CAP) (Sigma, C3175), 25 µ M FCCP (Sigma, C2920) or 5 mM 
NAC (Sigma, A9165). Cells were periodically tested for mycoplasma using PCR 
(primers provided in Supplementary Table 3) and results were negative.
Generation of retrovirus and lentivirus and stable cell lines. For viral production, 
HEK293T cells were seeded in 10-cm plates 24 h before transfection with 
polyethyleneimide (PEI; Polysciences Euro). For lentivirus, a mixture of 10 μ g 
lentivirus-short hairpin RNA, 2 μ g REV, 6 μ g RSV-RRE and 2 μ g VSV-G plasmids47 
with 78 μ l PEI and 900 μ l 150 mM NaCl was added to the cell culture media. For 
retrovirus, a mixture of 10 μ g retroviral vector DNA, 9 μ g GAG-Pol (pCL-Eco)48 
and 1 μ g VSV-G plasmids with 78 μ l PEI and 900 μ l 150 mM NaCl was added to the 
cell culture media. In both cases, 16 h later, cells were washed in PBS and the media 
replaced. After 48 h, the viral supernatant was removed, cleared with a 0.45 μ m filter 
and incubated with target cells. Three days after infection, cells were selected with 
puromycin (Sigma, P8833-25MG) for 5 days and subsequently maintained in normal 
growth medium. Lentivirus shRNA constructs were purchased from the Sigma 
MISSION lentiviral library against EXD2 (sh31: TRCN0000051631 (NM_018199.1-
155s1c1); sh22: TRCN0000327822 (NM_018199.2-1001s21c1)), and shRNA against 
GFP (SCH005) and sh-non-targeter (shNT, SHC016) were used as controls.
Generation of EXD2-KO cells with CRISPR–Cas9. Forward and reverse 
oligonucleotides containing the guide sequence were annealed and cloned into 
pX330-U6-Chimeric_BB-CBh-hSpCas9 (a gift from F. Zhang; Addgene plasmid 
no. 42230)15 modified to coexpress enhanced GFP (a gift from C. Cortina and 
E. Batlle), and this construct was transfected into U2OS and MDA-MB-231 cells 
using Lipofectamine 2000 Transfection Reagent (ThermoFisher). GFP-positive 
cells were sorted 24 h after transfection (BD FACSAria III SORP) and expanded 
from single cells. Screening for EXD2-KO cells was carried out by western blotting. 
Two clones each of U2OS and MDA-MB-231 showing complete loss of EXD2 
protein were selected for further phenotypic analysis.
Isolation of DNA, RNA and cDNA preparation. For DNA isolation of human 
cancer cell lines, 1,000,000 cells were plated on 10 cm plates and collected 24 h later 
in 515 μ l of lysis buffer (75 mM NaCl, 50 mM EDTA, 0.02% SDS, 0.4 mg ml–1 PK). 
Lysate was transferred to 1.5 ml Eppendorf tubes and incubated at 50 °C for 2 h. 
Isopropanol (1 volume) was added and mixed and incubated at 4 °C overnight. 
Tubes were centrifuged at 8,500g for 30 min at 4 °C and pellets washed with 
70% ethanol and air dried. DNA was resuspended in TE buffer and diluted to 
100 ng ml–1 for quantitative PCR. D. melanogaster DNA was obtained from adult 
flies that were snap frozen in liquid nitrogen and the abdomens homogenized with 
a pestle in grinding buffer (0.2 M sucrose, 0.1 M Tris buffer pH 9.2, 50 mM EDTA 
and 0.5% SDS) and incubated at 65 °C for 10 min. Potassium acetate was added to a 
final concentration of 5 M and the samples were incubated on ice for 20 min. DNA 
was precipitated with phenol:chloroform:ethanol. Total RNA was isolated using a 
PureLink RNA mini kit (Ambion) according to the manufacturer’s instructions. 
Total RNA (1 μ g) was used as a template for cDNA synthesis using a High Capacity 
RNA-to-cDNA kit (ThermoFisher).
Quantitative RT-PCR. Quantitative RT-PCR (qRT-PCR) was performed using 
a Step-One-Plus real-time PCR instrument (Applied Biosystems) and quantified 
using the comparative CT method. Amplification was performed using Power 
SYBR Green PCR master mix (Applied Biosystems, 4309155). Analysis of EXD2 
mRNA levels was performed using Taqman probes from Applied Biosystems 
(EXD2 Hs00217045_m1, ACTB 4352935E) together with Taqman master mix 
(Applied Biosystems). Primers used are provided in Supplementary Table 3.
Flow cytometry-based assays for mitochondrial function. For the analysis of 
mitochondrial mass, 150,000 cells were seeded in 6-well plates in duplicate 24 h 
before analysis. Cells were incubated for 30 min with 250 nM MitoTracker Green 
FM or Deep Red probes (ThermoFisher) in normal growth medium at 37 °C.  
Cells were trypsinized and washed with warm PBS once, stained with 500 nM  
4 ′ ,6-diamidino-2-phenylindole, dihydrochloride (DAPI) and immediately 
analysed by flow cytometry. To detect intracellular and mitochondrial ROS 
production, 150,000 cells were seeded in 6-well plates in duplicate 24 h before 
analysis. Cells were incubated at 37 °C for 30 min in 5 μ M MitoSox (Molecular 
Probes, M36008) and then trypsinized and washed with warm PBS once and 
analysed immediately by flow cytometry. Data were collected with a Gallios flow 
cytometer using Kaluza for Gallios software (Beckman Coulter) and analysed using 
FlowJo v9.9.6 (FlowJo LLC). Data were plotted and statistically analysed in Prism 7, 
and examples provided in Supplementary Fig. 8.
Immunofluorescence. For immunofluorescence, cells were fixed with 4% 
formaldehyde for 10 min at room temperature. After two washes with PBS, 
cells were permeabilized with PBS containing 2% Triton X-100 for 10 min 
at room temperature. Cells were washed twice with PBS and incubated with 
primary antibody (1:500) in PBS-T containing 10% FBS for 1 h at room 
temperature. After two washes with PBS-T, cells were incubated with secondary 
antibody (1:500) in PBS-T containing 10% FBS and DAPI for 1 h at room 
temperature. Slides were rinsed in PBS-T, washed twice for 5 min in PBS-T and 
mounted with Vectashield (Vector Laboratories, H-1000). Drosophila embryos 
(0–15 h) were collected, dechorionated with bleach for 90 s and rinsed with 0.1% 
Triton X-100. Embryos were incubated in a solution containing 4% formaldehyde 
and heptane (1:1) for 20 min in a rotator at room temperature. Formaldehyde was 
replaced with methanol, samples were vortexed for 20 s and the embryos were 
transferred to new vials and washed extensively with PBS-T containing 0.3% 
bovine serum albumin (BSA). Samples were incubated with primary antibody for 
4 h at room temperature, and after two washes with PBS-T they were incubated 
with secondary antibody for 2 h at room temperature, followed by an incubation 
with DAPI for 15 min at room temperature. Embryos were rinsed in PBS-T, washed 
twice for 5 min in PBS-T containing 0.3% BSA and mounted with Fluoromount 
(Sigma, F4680). Adult ovaries from Drosophila were dissected in Schneider 
medium and fixed in 4% formaldehyde in PBS for 20 min at room temperature. 
After washing with PBS, they were permeabilized with 1% Triton X-100 in PBS 
for 2 h and then incubated in PBS-T (1% (w/v) BSA, 0.2% Triton X-100, PBS) 
for 1 h. Ovaries were then incubated with primary antibodies diluted in PBS-T 
overnight at 4 °C. The next day, the ovaries were washed with PBS, incubated in 
the dark with secondary antibodies diluted in PBS-T for 3 h at room temperature 
and further stained with rhodamine–phalloidin (Biotium, no. 00027) and Hoechst 
(Sigma) for 20 min. After final washes with PBS, ovaries were mounted with 
Vectashield. Images were acquired with a Leica SPE confocal microscope and 
cropped in ImageJ49. Depth (z) thresholds were set accordingly to capture the 
entire architecture. In some cases, brightness and contrast were adjusted in ImageJ 
(v1.49b). Any changes were applied to all images equally for direct comparison. 
Antibodies used are provided in Supplementary Table 4.
Protein lysates, fractionation and western blotting. Cells were rinsed with PBS 
and collected in lysis buffer (50 mM HEPES, 16 mM NaCl, 1% NP-40, 0.5% DOC, 
0.1% SDS, 1× protease inhibitor cocktail (Roche, 04693132001) and phosphatase 
inhibitor cocktail (Sigma, P5726)). Samples were sonicated (15 s) for 30 min, 
spun down at 4 °C for 20 min at 12,000g and quantified with a DC Protein assay 
(Biorad, 500-0114). Total protein (50 μ g) was boiled for 10 min with loading dye 
(50 mM Tris-Cl (pH 6.8), 0.3% SDS, 0.1% bromophenol blue, 10% glycerol, 0.4% 
ß-mercaptoethanol) and separated by SDS–PAGE followed by electrophoretic 
transfer to polyvinylidene difluoride (PVDF) membrane (Millipore). Membranes 
were blocked for 20 min in PBS-T with 5% dry milk and primary antibody 
(in PBS-T with 5% dry milk) was added for either 1 h at room temperature or 
overnight at 4 °C. Membranes were washed three times in PBS-T and incubated 
with secondary antibody (in PBS-T with 5% dry milk) for 1 h at room temperature. 
After three PBS-T washes, ECL-reagent (Amersham, RPN2132) and X-ray film 
(Fujifilm, 47410 19236) were used to detect signals. Antibodies used are listed 
in Supplementary Table 4. Separation of cellular compartments was performed 
according to the manufacturer’s instructions with a Standard Cell Fractionation kit 
(Abcam, ab109719). Further HCl treatment of the nuclear fractions was used for 
chromatin extraction. Alternative chromatin fractionation (Supplementary Fig. 7c) 
was performed as described previously8. U2OS cells were resuspended in buffer 
A (10 mM HEPES-KOH pH 7.9, 10 mM KCl, 1.5 mM MgCl2, 340 mM sucrose, 
10% glycerol, 1 mM DTT, 1× protease inhibitor cocktail (Roche, 04693132001) 
and phosphatase inhibitor cocktail (Sigma, P5726)) and Triton-X100 was added 
to a final concentration of 0.1%. After incubation on ice for 5 min, samples 
were centrifuged at 1,300g for 4 min. Pelleted nuclei were washed with buffer A, 
resuspended in buffer B (3 mM EDTA, 0.2 mM EGTA, 1 mM DTT, 1× protease 
inhibitor cocktail (Roche, 04693132001) and phosphatase inhibitor cocktail 
(Sigma, P5726)) and lysed for 20 min on ice. After centrifugation at 1,700g for 
5 min, the supernatant (nuclear soluble fraction) was collected, and the pellet 
(chromatin fraction) was washed with buffer B, resuspended in urea buffer (9 M 
urea, 50 mM Tris-HCl pH 7.3) and sonicated.
Submitochondrial fractionation. PK treatment of mitochondria was performed 
as previously described50. Briefly, U2OS cells were homogenized in ice-cold MB 
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buffer (210 mM mannitol, 70 mM sucrose, 10 mM HEPES-KOH pH 7.4 and 1 mM 
EDTA) with a glass Dounce homogenizer (40 tight strokes) and mitochondria 
were obtained by differential centrifugation. To test susceptibility to protease, 
mitochondria (100 μ g) were resuspended in MB buffer (200 μ l), swelling buffer 
(10 mM HEPES-KOH pH 7.4) or MB + 0.2% (v/v) Triton X-100. PK was added 
to a final concentration of 50 μ g ml–1 and the samples were incubated on ice for 
30 min. Proteolysis was stopped by adding 2 mM phenylmethylsulfonyl fluoride. 
Samples were precipitated with trichloroacetic acid (Sigma, T6399) and analysed 
by SDS–PAGE. Analysis of differential protein retention after FCCP treatment was 
performed by treating U2OS cells with 25 μ M FCCP for 24 h. Separation of cellular 
compartments was performed according to the manufacturer’s instructions with a 
Standard Cell Fractionation kit (Abcam, ab109719). Further HCl treatment of the 
nuclear fractions was used for chromatin extraction.
Metabolomic analysis of human cell lines. A combination of liquid 
chromatography (LC)–MS and gas chromatography (GC)–MS analysis performed 
by Metabolon (www.metabolon.com)12 was used for the detection of a total of 
253 metabolites in cell extracts. Analysis was performed using five independent 
cultures of control U2OS cells selected with a stable shRNA against GFP (shCont) 
or EXD2 (shEXD2-22). Cells were collected, snap frozen and metabolites were 
extracted using a proprietary series of organic and aqueous extractions and divided 
into two fractions for analysis using LC–MS, LC–MS2 and GC–MS. LC–MS 
was based on a Waters ACQUITY ultra-performance liquid chromatography 
system and a Thermo-Finnigan LTQ mass spectrometer, which consisted of an 
electrospray ionization source and linear ion-trap mass analyser. Samples for GC–
MS were re-dried under vacuum desiccation for a minimum of 24 h before analysis 
and derivatized under dried nitrogen using bistrimethyl-silyl-triflouroacetamide 
(BSTFA; Sigma, 33024). The GC column was 5% phenyl and the temperature ramp 
was from 40 °C to 300 °C in a 16 min period. Samples were analysed on a Thermo-
Finnigan Trace DSQ fast-scanning single-quadrupole mass spectrometer using 
electron impact ionization.
For 13C stable isotope tracer analysis, 6 × 106 U2OS cells stably expressing 
the indicated shRNA constructs were seeded on 15-cm tissue culture plates 
in triplicate. The following day, cells were rinsed twice in PBS and 20 ml 
media (DMEM without glucose, without glutamine, 10% FBS, 1× penicillin–
streptomycin) containing 5 mM glucose (unlabelled or [U13C6]-D-Glucose, 
Cambridge Isotope Laboratories, CLM-1396-1) or 2 mM glutamine (unlabelled 
or [U-13C5]-Glutamine, Cambridge Isotope Laboratories, CLM-1822-H-0.1) was 
added to the cells for 6 h. Cells were collected by trypsinization and 10 × 106 cells 
were pelleted and snap frozen, after which the metabolites were extracted into 
solvent by adding 2 ml of ice-cold chloroform:methanol (2:1 v/v). The suspension 
was bath sonicated for 3 min, and 2 ml of cold water was added. Then, 1 ml 
of chloroform:methanol (2:1 v/v) was added to the samples followed by bath 
sonication for 3 min. Cell lysates were centrifuged (5,000g for 15 min at 4 °C) 
and the aqueous phase transferred into a new tube. Samples were frozen until 
analysis using PEPA13. PEPA detects the position of carbon labels in isotopically 
enriched metabolites and quantifies fractional enrichment through the indirect 
determination of 13C-satellite peaks using one-dimensional 1H-NMR spectra.
LC–MS analyses. Metabolites were extracted from snap-frozen cell pellets by 
adding 200 µ l of cold acetonitrile:water (1:1) with 1% metaphosphoric acid 
and 0.1% formic acid (previously filtered, 1:1 v/v). Samples were vortexed for 
30 s and immersed in liquid N2 to disrupt cell membranes followed by 30 s of 
bath sonication; these two steps were repeated three times. Then, samples were 
incubated at − 20 °C for 2 h. Finally, samples were centrifuged at 17,000g for 15 min 
and the supernatant was collected into a LC–MS vial. Samples were injected in 
a ultra-high performance liquid chromatography system (1290 Agilent) coupled 
to a triple quadrupole (QqQ) mass spectrometer (6490 Agilent Technologies) 
operated in multiple reaction monitoring (MRM) and positive (POS) or negative 
(NEG) electrospray ionization mode. Metabolites were separated using C18-RP 
(ACQUITY UPLC BEH C18 1.7 μ M, Waters) chromatography at a flow rate of 
0.3 ml min–1. The solvent system was A (20 mM ammonium acetate,15 mM NH3 
in water) and B (acetonitrile:water (95:5)). The linear gradient elution started 
at 100% A (time 0–2 min), 65% A (time 2–5 min) and finished at 100% B (time 
5.5 min). MRM transitions were as follows: reduced glutathione (GSH; NEG, 
306 → 143.2, 128); oxidized glutathione (GSSG; NEG, 611.1 → 306.2, 143); ATP 
(POS, 508 → 136, 410); and ADP (POS 428 → 136, 348). Cellular ATP content 
was determined using a luminescence assay (ThermoFisher) according to the 
manufacturer’s instructions, and the relative ATP levels were normalized by the 
protein content of each sample.
Seahorse Bioanalyzer analysis. Cellular respiration was measured using a 
Seahorse XF24 Bioanalyzer (Seahorse Biosciences). U2OS and MDA-MB-231 
cells were seeded at 50,000 and 75,000 cells per well, respectively, on XF24 V7 PS 
cell culture microplates (Seahorse Biosciences, 100777-004) and cultured for 16 h 
before the analysis. The analysis was performed according to the manufacturer’s 
instructions in DMEM (Seahorse Biosciences, 102353-100) supplemented with 
5.5 mM D-glucose and 2 mM L-glutamine for the OCR experiments. For OCR 
measurements (Mito Stress Test), the following reagents were added: oligomycin 
(1 μ M), FCCP (0.4 μ M), and rotenone (1 μ M) and antimycin A (1 μ M). For the 
ECAR analysis (Glycolysis Stress Test), the following reagents were added: glucose 
(10 mM), oligomycin (1 μ m) and 2-deoxy-D-glucose (50 mM). For the OCR 
analysis of individual complexes, digitonin (25 μ g ml–1) was added to the media to 
allow cells to permeabilize for approximately 1 h, followed by sequential injections 
of malate (2.5 mM) and pyruvate (5 mM), rotenone (1 μ M), succinate (10 mM) and 
antimycin (5 μ M). Results were normalized to protein content using a DC Protein 
assay (Biorad, 500-0114).
BioID analysis of proximity interactions. EXD2 and EXD2-C2 were PCR 
amplified from previously described clones, and dExd2 was amplified 
from sequence-verified cDNA clones purchased from Gene Synthesis (Life 
Technologies) with primers containing 5 ′ AscI or 3 ′ NotI restriction sites (see 
Supplementary Table 3 for primers) using KOD Hot Start DNA Polymerase 
(Millipore) and cycling conditions recommended by the manufacturer: polymerase 
activation at 95 °C for 2 min, denaturation at 95 °C for 20 s, annealing at 55 °C 
for 10 s, and extension at 70 °C for 50 s (repeated for 40 cycles). PCR products 
were purified using a PureLink Quick Gel Extraction kit (Invitrogen) and cloned 
into pCR2.1-TOPO vector (Invitrogen). Top10 competent Escherichia coli cells 
(Invitrogen) were transformed with pCR2.1-TOPO clones and colonies were 
selected in carbenicillin. Constructs were verified by restriction digestion and 
sequencing (Macrogen) with primers for the TOPO vector (T7 Promoter-F and 
M13-R). EXD2, EXD2-C2 and dExd2 were then cut from the pCR2.1-TOPO vector 
by restriction digestion with AscI (NEB) and NotI-HF (NEB), purified using the 
PureLink Quick Gel Extraction kit and ligated into pcDNA5/FRT/TO-C-FLAG-
hBirA* (a gift from B. Raught) using a Quick Ligation Kit (BioLabs). Top10 
competent E. coli cells (Invitrogen) were transformed and carbenicillin selected, 
and the constructs were confirmed by restriction digestion and sequencing 
(Macrogen). For expression in Drosophila S2 cells, dExd2–BirA*–FLAG was 
PCR amplified and subcloned into the pMK33-C-TAP-FLAG-HA-BD plasmid 
backbone (Flybase: FBmc0003027).
AD293 cells were seeded and transfected the next day with BirA* vectors using 
PEI (Polysciences Euro) with or without 50 μ M biotin (IBIAN Biotechnology, 
2-1016-002). For mass spectrometry, Five 15-cm plates per condition were harvested 
24 h post-transfection by trypsinization, washing twice in PBS and snap frozen on 
dry ice. Cell pellets were lysed in 5 ml modified RIPA buffer (150 mM Tris-HCl 
7.5, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% Triton X-100, 0.1% SDS, 1:500 
protease inhibitor cocktail (Sigma-Aldrich), 1:1,000 benzonase (Novagen)) on ice 
and biotinylated proteins were isolated using streptavidin-sepharose beads (GE 
Healthcare). Proteins were washed in ammonium bicarbonate and digested with 
trypsin. Mass spectrometry was performed as previously described51.
Sucrose gradient analysis of mitochondrial ribosomes. U2OS cells were treated 
with 100 μ g ml–1 CAP and incubated at 37 °C for 10 min. Cells were then washed 
and homogenized in ice-cold STE buffer (250 mM sucrose, 5 mM Tris-HCl pH 7.5 
and 1 mM EGTA, 2 mM DTT, 100 μ g ml–1 CAP, 20 U ml–1 RNase inhibitors and 1× 
complete protease inhibitor) with a glass Dounce homogenizer (40 tight strokes). 
Mitochondria were obtained by differential centrifugation and loaded (0.9 mg) 
on a 5 ml linear sucrose gradient (10–30% (v/v)) in a gradient-forming buffer 
(20 mM Tris-HCl pH 7.5, 10 mM MgCl2, 100 mM KCl, 2 mM DTT, 100 μ g ml–1 
chloramphenicol, 20 U ml–1 RNase inhibitors and 1× complete protease inhibitor). 
The gradients were centrifuged in a Beckman Coulter MLS-50 rotor for 2 h at 
156,500g at 4 °C and fractions of 350 μ l were collected from the top and precipitated 
with trichloroacetic acid. Samples were then analysed by SDS–PAGE and qRT-PCR.
Analysis of mitochondrial translation. To analyse the rate of mitochondrial 
translation, experiments were performed essentially as previously described21 but 
with minor modifications. Cells (400,000) were plated on 6-cm plates the day 
before the experiment. Media was replaced with 2 ml DMEM lacking methionine or 
cysteine (Life Technologies) with 10% dialysed FBS (Hyclone) for 20 min.  
A volume (100 μ l) of 6 mg ml–1 sterile filtered emetine (Sigma) in PBS was added 
to the media for 10 min followed by the addition of 200 μ Ci ml–1 of 35S EasyTag 
(Perkin Elmer) for 1 h. For some experiments, CAP (Sigma) was added at 40 μ g ml–1 
to inhibit mitochondrial translation or the antioxidant NAC (5 mM; Sigma) was 
added. Labelling media was removed and cells washed twice in PBS followed by 
a 10 min incubation in DMEM with 10% FBS and penicillin–streptomycin. Cells 
were washed three times in PBS and scraped into 1 ml PBS. Following gentle 
centrifugation at 1,000g, cell pellets were resuspended in RIPA buffer (50 mM 
Tris–HCl pH 7.5, 150 mM NaCl, 1% NP-40, 1 mM MgCl2, 1× EDTA-free protease 
inhibitor cocktail (Roche)), nuclei pelleted by centrifugation at 2,000g for 10 min 
and the protein concentration determined by a modified BCA assay (Biorad). 
Lysate (20–40 μ g) was run on a 14% SDS–PAGE gel and transferred to a PVDF 
membrane by western blotting. Dried membranes were exposed to a Storage 
Phosphor Screen (Molecular Dynamics) for 3–8 days and imaged using a Typhoon 
8600 Variable Mode Imager (Molecular Dynamics). Contrast was adjusted and 
band intensity was quantified using ImageJ49. In organello Drosophila translation 
assays were performed as previously described27. Briefly, mitochondria were isolated 
from third-instar larvae and treated with 200 μ g ml–1 emetine and 100 μ g ml–1  
cyclohexamide to inhibit cytoplasmic translation. Isolated mitochondria (0.4 mg) 
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were incubated with 178 μ Ci 35S EasyTag (Perkin Elmer) for 1 h at 30 °C, and equal 
amounts of mitochondrial protein were loaded on a 14% SDS–PAGE gel and 
transferred to a PVDF membrane for western blotting at 100 V for 1 h. Labelled 
proteins were visualized by autoradiography as previously described.
Protein purification and enzymatic assays. Recombinant EXD2 (61–621) 
was used for protein expression because of its improved solubility and yield. 
Recombinant EXD2 was PCR amplified and cloned into pet28a with an N-terminal 
His-SUMO tag using BsmBI and XbaI and protein was expressed in E. coli 
Bl21(DE3)pLysSRARE by the addition of 1 mM isopropyl- β -D-thiogalactoside 
(IPTG) at 25 °C for 3 h. Soluble proteins were purified using nickel affinity resin 
in 50 mM Tris pH 7.5, 500 mM NaCl, 10% glycerol and eluted with increasing 
imidazole concentrations (up to 300 mM). The resulting protein was then further 
purified by gel filtration using a Superdex 200 10/300 GL column (GE Healthcare) 
in 50 mM Tris pH 7.5, 500 mM NaCl, and 10% glycerol. To confirm the activity was 
that of EXD2 rather than potential contaminants, mutations D108A and E110A 
(EXD2-NUC) were generated in the active site by site-directed mutagenesis. In 
addition, an EXD2–C1/2 mutant was generated (420CxxC to SxxS and 460CxxC 
to SxxS) using a QuikChange Lightning Site-Directed Mutagenesis kit (Agilent 
Technologies, 210518-5). These proteins were then expressed and purified as 
described for the wild-type protein.
WRN-EXO (1–333) was purified as previously described52. Briefly, the 
protein was expressed in E. coli Bl21(DE3)pLysSRARE by adding 1 mM IPTG 
and incubating at 25 °C for 4 h. Protein was purified on nickel affinity resin in 
50 mM Tris pH 7.5, 500 mM NaCl and 10% glycerol, and by Q ion exchange 
chromatography in 50 mM Tris pH 7.5, and 10% glycerol followed by gel filtration 
using an S200 column in 50 mM Tris pH 7.5, 500 mM NaCl and 10% glycerol.
For enzymatic activity assays, 5–80 nM protein was incubated with 20 nM 5 ′  
FAM (5-carboxyfluorescein) or Cy5 labelled DNA–RNA in 50 mM Tris pH 7.5, 
0.5 μ g ml–1 BSA and 10% glycerol with the addition of 10 nM MnCl2 or MgCl2. 
Reactions were incubated at 37 °C for 30 min before DNA was denatured by boiling 
in 35% formamide. For substrates containing RNA, 50% formamide was added 
and no boiling step was used. DNA was separated on an 18% polyacrylamide urea 
TBE gel (21 W for 2 h) and products were visualized using a Fujifilm FLA-5100 
image reader. For the blocked 5′ end oligo assay, 0.5 units ExoI (NEB) was used as 
a positive control and the reaction was carried out in the supplied reaction buffer. 
Oligonucleotides were annealed to form double-stranded substrates in 10 mM Tris 
pH 7.5 by boiling followed by slow cooling.
EMSAs. For EMSAs, 20–310 nM protein was incubated with 20 nM 5′ FAM 
or Cy5 labelled DNA–RNA in 50 mM Tris pH 7.5, 0.5 μ g ml–1 BSA and 10% 
glycerol and incubated on ice for 30 min. Complexes were then separated on 
an 8% polyacrylamide gel in 0.5× TBE (75 V for 80 min) and products were 
visualized using a Fujifilm FLA-5100 image reader. All primers used are listed in 
Supplementary Table 3.
Drosophila stocks and maintenance. D. melanogaster with a transposon insertion 
mapped to CG6744/dExd2 (y1 w67c23; P{EPgy2}CG6744EY03872; stock no. 16578) were 
obtained from the Bloomington Drosophila Stock Center at Indiana University 
(http://flystocks.bio.indiana.edu/) and the reduced transcript level was confirmed 
by qRT-PCR as described under 'Quantitative RT-PCR'. Flies were maintained at 
25  °C on a 12 h:12 h light:dark cycle at constant humidity. Flies were back-crossed 
to our control yellow white flies for eight generations before performing the 
analyses reported here.
Drosophila food preparation. For lifespan analysis, different fly-food formulations 
were prepared as follows: normal food (100 g yeast, 100 g sugar, 20 g agar, 30 ml 
nipagen and 3 ml propionic acid per liter of food); low-sugar food (100 g yeast, 50 g 
sugar, 20 g agar, 30 ml nipagen and 3 ml propionic acid per liter of food); low-yeast 
food (50 g yeast, 100 g sugar, 20 g agar, 30 ml nipagen and 3 ml propionic acid per 
liter of food); antioxidant food (100 g yeast, 100 g sugar, 20 g agar, 30 ml nipagen, 
3 ml propionic acid and 10 mg ml–1 NAC per liter of food); and paraquat food 
(100 g yeast, 100 g sugar, 20 g agar, 30 ml nipagen, 3 ml propionic acid and 5 mM 
paraquat). To prepare each diet, yeast, sucrose and agar were first dissolved in 
water and boiled for 10 min. After cooling, propionic acid and nipagen were added, 
and the food was distributed into glass vials and allowed to solidify. Finally, NAC 
or paraquat was added to the specific diets.
Analysis of Drosophila lifespan, fecundity and development. To assess lifespan, 
newly hatched flies from each genotype were allowed to mate for 48 h, after which 
females and males were separated and grouped into 30 flies per vial. Food vials 
were changed every 3 days, and deaths were scored until all flies were dead.  
To determine fecundity, age- and diet-specific flies from each genotype were 
allowed to mate for 4 h and fecundity was estimated from six independent egg 
counts. The mean number of eggs per fly was calculated. For the analysis of 
development, 0–4 h embryos were collected on grape-juice agar plates. To assess 
pupariation, 40 newly hatched larvae were transferred to specific-food vials.  
Once the L3 stage was reached, larvae were monitored and new pupae were 
counted every 2 h. For size measurements, 0–4 h embryos and pupae were 
mounted for imaging and processed using ImageJ49. Expression data shown in 
Supplementary Fig. 6c was obtained from ModENCODE/FlyBase53,54.
Culture and transfection of Drosophila S2 cells. Drosophila S2 cells were 
maintained at 25 °C in Schneider’s Drosophila medium (Lonza) supplemented 
with 10% (v/v) FBS (Gibco, 10270-500ML) and 50 μ g ml–1 penicillin–streptomycin 
(Gibco, 15140-122). S2 cells were transfected using Effectene (Qiagen, 301425) 
following the manufacturer’s protocol.
Oxygen consumption measurement. Oxygen consumption was measured in 
inverted and permeabilized larval tissues using an Oxygraph-2k (Oroboros) as 
previously described55. Mitochondrial-dependent respiration was measured by 
supplying the following ETC substrates: 10 mM glutamate, 2 mM malate, 2.5 mM 
ADP and 10 mM succinate. Larvae were then stressed with 0.5 μ M of FCCP 
to measure maximal respiration, and the ETC was inhibited by adding 0.5 μ 
M rotenone and 2.5 μ M antimycin. Final values were normalized to the protein 
content of each sample.
TEM. HEK293T cells stably overexpressing EXD2–SF-WT or empty control SF 
vector (Cont-SF) were grown to 80% confluency, washed three times in PBS and 
fixed in 2.5% glutaraldehyde for 1 h. Cells were detached by scraping and pelleted 
(4 °C, 587g in an Eppendorf 5424 rotor for 10 min). Pellets were washed in 0.1 M 
phosphate buffer (PB) four times for 10 min, stained with 1% OsO4 for 1 h and 
washed again for 10 min in 0.1 M PB. Cells were dehydrated at 4 °C using a series 
of acetone concentrations (50, 70, 90, 96, 100%) before embedding. Sections were 
cut with a UCT ultramicrotome (Leica Microsystems) and incubated with blocking 
buffer (5% and 1% BSA) in 0.01 M PBS solutions for 10 and 1 min, respectively). 
Grids were incubated for 30 min at room temperature with polyclonal FLAG 
antibody (Sigma) diluted 1:10 in blocking buffer (1% BSA in 0.01 M PBS). After 
four washes (0.25% Tween-20 in 0.01 M PBS for 4 min and 1% BSA in 0.01 M PBS 
for 1 min), sections were incubated with immunoglobulin M anti-rabbit-coupled 
colloidal gold particles (Jackson, West Grove, USA) diluted in blocking buffer for 
15 min, rinsed with water, rinsed in 0.01 M PBS, fixed in 1% GA in 0.01 M PBS, 
and rinsed abundantly in double-distilled water. Sections were stained with 1% 
potassium permanganate and 1% uranyl acetate  in water for 15 min. Controls for 
non-specific binding of the colloidal gold-conjugated antibody were performed 
by omitting the primary antibody. Electron micrographs were obtained using a 
Jeol JEM 1010 MT electron microscope (Japan) operating at 80 kV in the Electron 
Microscopy core unit of the Parc Cientific de Barcelona.
Alamar Blue survival assays. Measurements were made according to 
manufacturer’s instructions (Invitrogen, DAL1025). Briefly, cells were seeded at a 
density of 300 cells per well in 96-well plates and allowed to attach overnight. After 
completion of drug treatments (7 days), a dilution 1:10 of Alamar Blue reagent in 
medium was added to each well. After 2–4 h incubation at 37 °C, fluorescence was 
measured in a FL600 Microplate Fluorescence Reader (BIOTEK).
Colony formation assays. For colony formation assays, cells were seeded at a 
density of 300 cells per well in 6-well plates and allowed to attach overnight. After 
completion of drug treatments (12 days), cells were stained with 0.1% crystal violet 
in 20% methanol. The number of colonies was analysed using ImageJ49. Cells were 
treated with the indicated doses of camptothecin-11 (Sigma, I1406), mitomycin-C 
(MMC; Sigma, M4287) or olaparib (Selleckchem, AZD2281).
Blue native PAGE. Blue native PAGE analysis was performed according to a 
previously published protocol56. Briefly, 200 μ g of mitochondria were isolated from 
U2OS cells, solubilized with 8 g per gram of digitonin and loaded into a gradient 
gel. Coomassie staining allowed for the identification of mitochondrial complexes.
MitoString assay. Total RNA was isolated according to the manufacturer’s 
instructions (a PureLink RNA mini kit, Ambion). The MitoString assay was 
performed as previously described28.
2D agarose gel electrophoresis of mitochondrial replication intermediates. 
2D agarose gel electrophoresis was carried out as previously described57. Briefly, 
total DNA was extracted from 4 × 106 cells using phenol:chloroform and PK. Total 
DNA (30 µ g) was digested with HinCII (NEB) and DNA was then separated in 
the first dimension on a 0.4% TBE agarose gel without ethidium bromide for 18 h 
at 1.1 V cm–1. The lane was then cut from the gel and rotated 90° and the DNA 
was further separated in a 1 % TBE agarose gel containing 500 ng ml–1 ethidium 
bromide for 6 h at 260 mA, 4 °C. The gel was Southern blotted and DNA was 
identified using a radioactive probe made using Ready-To-Go dCTP DNA labelling 
beads (GE Healthcare). The probe was specific to region 16341-151 and was 
generated by PCR58 (primer sequences are provided in Supplementary Table 3). 
Labelled membranes were exposed to a phosphor screen that was scanned using a 
Fujifilm FLA-5100 image reader.
Computational and phylogenetic analysis. Human EXD2 was used as a query 
in phmmer searches in a database of reference proteomes focusing on the 
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UNIPROT reference proteomes having complete genomes. We extracted the EXO 
domain multiple sequence alignment from the PFAM database (PFAM name 
is DNA_pol_A_exo1), built a hidden Markov profile from the seed alignment 
using HMMER (http://hmmer.org/) and searched in our database of Reference 
proteomes with this profile. Then we collected all the sequences with an EXO 
domain (~300 sequences). The HNH domain was extracted from PFAM (PFAM 
name HNH) and we built a hidden Markov profile for searching our database. 
EXD2_HUMAN was recovered at a significant e-value above threshold. We 
next scanned all the sequences for additional domains using hmmscan (from 
the HMMER suite) to annotate the sequences. Multiple sequence alignments of 
proteins were conducted using MAFFT in its slow and accurate version (L-IN-SI)59. 
Alignments were visualized in Belvu60 and Jalview61. Sequence alignments shown 
in Supplementary Fig. 1a,c–e were performed using the T-Coffee webserver62, the 
output formatted in Jalview61 and modified in Adobe Illustrator. Mitochondrial 
targeting probability was predicted using MitoProt II62.
For the phylogenetic analysis, we conducted two different phylogenies, using 
only the EXO domain; a large tree of ~290 sequences, including a large number 
of bacterial sequences (available upon request), and a refined tree including 
representative sequences exhibiting different domain arrangements (Supplementary 
Fig 1b). We conducted probabilistic-based phylogenies using MrBayes63. A total of 
four independent chains with four runs were run under a mixed model of evolution 
over 5 million generations. Twenty-five percent of initial trees were discarded and a 
total of 1,500,004 trees were sampled. The following specific parameters were used 
to run the search: prset aamodelpr = mixed; lset rates = gamma; relburnin = yes 
burningfrac = 0.5. The tree was annotated using in-house scripts to show the 
domain distributions associated with the EXO domains in these sequences and 
visualized using iTOL64. Additional analyses were run using alternative ML–base 
methods, in particular RA× ML, giving the same topologies.
For the structural bioinformatic analysis of the EXD2 HNH domain (amino 
acids 408–470), the EXD2 HNH-like domain was modeled using SCWRL65 and 
superimposed on the PDB structures with the best Fold and Function Assignment 
(FFAS03)66 scores (5 × 42: Legionella pneumophila DotN: score –15, 5H0M: deep-
sea thermophilic bacteriophage GVE2 HNH endonuclease67: score –12.0, 5MKW: 
human ZRANB3 HNH domain68: score –11.7, and 1OGY: heterodimeric nitrate 
reductase NAPB from Rhodobacter sphaeroides69: score –11.1). Several structures 
were obtained as reliable templates (between − 9 and − 16) and the best scoring 
template in terms of alignment length, %identity and %of gaps (5H0M) was used 
to generate the model presented in Supplementary Fig. 1d.
Statistics and reproducibility. Statistical analysis was performed using Prism 
7 and R. An unpaired two-tailed t-test was performed when comparing two 
groups except when stated otherwise. An analysis of variance (ANOVA) test was 
used when comparing more than two groups, followed by Dunnett’s multiple 
comparison test. For metabolomics data, raw data was median-centered, and 
metabolite levels compared between shCont and shEXD2-22 groups using a two-
tailed t-test. False discovery rate was controlled using the Benjamini and Hochberg 
procedure (adjusted P < 0.1 and a fold change (FC) > 1.3 in absolute value was 
used for statistical significance). Data analysis was performed using R version 
3.2.0. MetPa70 was used to perform pathway enrichment and topological analysis. 
Survival or cumulative hazard functions were estimated using the Turnbull 
method for interval censored data using Kaplan–Meier estimates as a baseline 
and comparisons performed by proportional-hazard Cox models with interval 
censored data implemented in R package (https://cran.r-project.org/web/packages/
icenReg/index.html). GSC attrition was analysed with a proportional odds 
cumulative link model (ordinal regression) implemented in R package (https://
cran.r-project.org/web/packages/ordinal/index.html). P values were adjusted for 
multiple testing using the Benjimini and Hochberg method and hazard ratios and 
their corresponding 95% confidence intervals were computed as a measure of 
association for data in Figs. 7i, 8a and 8e. Source data and statistical information is 
shown in Supplementary Table 1. Reproducibility of representative data: Figs. 1a,b 
and 2b: representative of five experiments; Figs. 1d, 3e, 4d, 5e–f, 6b–c, 6e–g, 
6i, 6k–l, Supplementary Figs. 2a, 4e, 5b–e, 5g–i, and 5k: representative of three 
experiments; Figs. 1e–f, 6d, 6h, 6m, Supplementary Figs. 2f, 5f, 5j, 5m, 6b, 6c, 7e, 
and 8f: representative of two experiments; Fig. 4a,e: representative of more than 25 
cells analysed in two experiments; Fig. 5a: top and middle panels, representative 
of three experiments, bottom panel representative of two experiments. Figure 5c, 
Supplementary Figs. 4b, 4c, and 4d: representative of seven experiments; Fig. 7h: 
representative of 30 or more animals per genotype; Fig. 8d: representative of 15 or 
more per animals per genotype; Supplementary Fig. 1f: representative of at least 49 
fields from one experiment; Supplementary Fig. 1g: representative of 25 fields from 
two experiments; Supplementary Figs. 1h and 4a: were performed once; Fig. 7e: 
representative of 30 cells from two experiments.
Life Sciences Reporting Summary. Further information on experimental design is 
available in the Life Sciences Reporting Summary.
Data availability. Metabolomics data and statistics used for Fig. 2c,f are provided 
in Supplementary Table 1. Raw data for Fig. 2 are available from the Metabolights 
repository (ID: MTBLS247). An annotated summary of BioID-MS data from Fig. 4 
is plotted in Supplementary Table 2, and raw data are available from the MassIVE 
repository (ID: MSV000081337). Additional source data and statistical information 
for all plotted figures are provided in Supplementary Table 1 and uncropped blots 
and gels are provided in Supplementary Figure 9. All other data and materials are 
available from the corresponding author upon reasonable request.
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 Experimental design
1. Sample size
Describe how sample size was determined. Evaluation of the data distribution and variation was performed in order to make 
sure the chosen statistical tests were appropriate. No statistical method was used 
to predetermine sample size.
2. Data exclusions
Describe any data exclusions. No samples or animals were excluded from the analyses.
3. Replication
Describe whether the experimental findings were
reliably reproduced.
All experiments were performed at least 3 times with similar results with the 
exception of Figs. 1e-f, 6d, 6h, 6m, Supplementary Figs. 2f, 5f, 5j, 5m, 6c, 6d that 
were performed 2 times with similar results and Supplementary Fig. 1h, 4a that 
were performed a single time. Details are provided in the Statistics and 
Reproducibility section of the Materials and Methods.
4. Randomization
Describe how samples/organisms/participants were
allocated into experimental groups.
The experiments were not randomized.
5. Blinding
Describe whether the investigators were blinded to 
group allocation during data collection and/or analysis.
Generally, the investigators were not blinded to allocation during experiments and 
outcome assessment. MS experiments were run blinded to the operators.
Note: all studies involving animals and/or human research participants must disclose whether blinding and randomization were used.
6. Statistical parameters
For all figures and tables that use statistical methods, confirm that the following items are present in relevant figure legends (or in the
Methods section if additional space is needed).
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The exact sample size (n) for each experimental group/condition, given as a discrete number and unit of measurement (animals, litters, cultures, etc.)
A description of how samples were collected, noting whether measurements were taken from distinct samples or whether the same 
sample was measured repeatedly
A statement indicating how many times each experiment was replicated
The statistical test(s) used and whether they are one- or two-sided (note: only common tests should be described solely by name; more 
complex techniques should be described in the Methods section)
A description of any assumptions or corrections, such as an adjustment for multiple comparisons
The test results (e.g. P values) given as exact values whenever possible and with confidence intervals noted
A clear description of statistics including central tendency (e.g. median, mean) and variation (e.g. standard deviation, interquartile range)
Clearly defined error bars
See the web collection on statistics for biologists for further resources and guidance.
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 Software
Policy information about availability of computer code
7. Software
Describe the software used to analyze the data in this
study.
No commercial or custom code was used. Graphpad Prism 7 was used to plot data 
and for some statistical analysis (ANOVA and t-test). Other statistical analysis was 
performed by the IRB Barcelona Biostatistics/Bioinformatics core facility using R as 
described in the Materials and Methods.
For manuscripts utilizing custom algorithms or software that are central to the paper but not yet described in the published literature, software must be made 
available to editors and reviewers upon request. We strongly encourage code deposition in a community repository (e.g. GitHub). Nature Methods guidance for 
providing algorithms and software for publication provides further information on this topic.
 Materials and reagents
Policy information about availability of materials
8. Materials availability
Indicate whether there are restrictions on availability of
unique materials or if these materials are only available
for distribution by a for-profit company.
All materials are available to the scientific community upon reasonable request.
9. Antibodies
Describe the antibodies used and how they were validated 
for use in the system under study (i.e. assay and species).
All antibodies are listed in Supplementary Table 4 with species, company/catalog# 
and dilution used per application. The EXD2 antibody was validated on human 
CRSIPR KO cells or cells expressing specific shRNAs against EXD2. Other antibodies 
were validated by extensive use in previous publications , control experiments 
(behavior in fractionation, localization) or by the distributor (TOM20, H3, ATP5A, 
NDUFA9, VDAC, Cytochrome-C, GFP, OXPHOS cocktail, GAPDH, Lamin, Hts, RPA2, 
ND6, MRPL3, MRPL12, DAP3).
10. Eukaryotic cell lines
a. State the source of each eukaryotic cell line used. AD293 cells were purchased from Stratagene. MDA-MB-231 cells were obtained 
from the lab of Dr. Roger Gomis and U2OS and RPE1 cell lines were purchased 
from ATCC. 
b. Describe the method of cell line authentication used. Morphology, behavior and several gene expression parameters were consistent 
with their identity but genetic validation was not carried out. 
c. Report whether the cell lines were tested for
mycoplasma contamination.
Cells were routinely tested for mycoplasma by PCR (primers provided in Table 3) 
and found negative.
d. If any of the cell lines used are listed in the database
of commonly misidentified cell lines maintained by
ICLAC, provide a scientific rationale for their use.
No. commonly misidentified cell lines were used
 Animals and human research participants
Policy information about studies involving animals; when reporting animal research, follow the ARRIVE guidelines
11. Description of research animals
Provide details on animals and/or animal-derived
materials used in the study.
No vertebrate animals were used.
Policy information about studies involving human research participants
12. Description of human research participants
Describe the covariate-relevant population
characteristics of the human research participants.
The study did not involve human participants.
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    Data presentation
For all flow cytometry data, confirm that:
1.  The axis labels state the marker and fluorochrome used (e.g. CD4-FITC).
2.  The axis scales are clearly visible. Include numbers along axes only for bottom left plot of group (a 'group' is an analysis of 
identical markers).
3.  All plots are contour plots with outliers or pseudocolor plots.
4.  A numerical value for number of cells or percentage (with statistics) is provided.
    Methodological details
5.   Describe the sample preparation. 150,000 U2OS or MDA-MB-231 cells were stained per sample with 
MitoTracker Green FM, MitoTracker Red or MitoSox Red. Cells were 
trypsinized and washed with warm PBS once, stained with DAPI (to identify 
dead cells) and analyzed by flow cytometry immediately. No fixation was 
used. 
6.   Identify the instrument used for data collection. Gallios, Beckman Coulter.
7.   Describe the software used to collect and analyze 
the flow cytometry data.
Data was collected using Kaluza for Gallios acquisition software (Beckman 
Coulter) and anlayzed using FlowJo v9.9.6 and Excel. Data was plotted and 
statistically analyzed in Prism7.
8.   Describe the abundance of the relevant cell 
populations within post-sort fractions.
No sorting was performed.
9.   Describe the gating strategy used. Dead cells were gated with DAPI staining and dye stained populations 
were validated by comparing to control treated samples: FCCP 
(MitoTracker) or Paraquat (MitoSox). Examples are shown in 
Supplementary Figure 8.
 Tick this box to confirm that a figure exemplifying the gating strategy is provided in the Supplementary Information.
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